Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned - PubMed (original) (raw)

Meta-Analysis

doi: 10.1038/mp.2010.109. Epub 2010 Nov 2.

M L Pergadia, D H R Blackwood, B W J H Penninx, S D Gordon, D R Nyholt, S Ripke, D J MacIntyre, K A McGhee, A W Maclean, J H Smit, J J Hottenga, G Willemsen, C M Middeldorp, E J C de Geus, C M Lewis, P McGuffin, I B Hickie, E J C G van den Oord, J Z Liu, S Macgregor, B P McEvoy, E M Byrne, S E Medland, D J Statham, A K Henders, A C Heath, G W Montgomery, N G Martin, D I Boomsma, P A F Madden, P F Sullivan

Affiliations

Free PMC article

Meta-Analysis

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned

N R Wray et al. Mol Psychiatry. 2012 Jan.

Free PMC article

Abstract

Major depressive disorder (MDD) is a common complex disorder with a partly genetic etiology. We conducted a genome-wide association study of the MDD2000+ sample (2431 cases, 3673 screened controls and >1 M imputed single-nucleotide polymorphisms (SNPs)). No SNPs achieved genome-wide significance either in the MDD2000+ study, or in meta-analysis with two other studies totaling 5763 cases and 6901 controls. These results imply that common variants of intermediate or large effect do not have main effects in the genetic architecture of MDD. Suggestive but notable results were (a) gene-based tests suggesting roles for adenylate cyclase 3 (ADCY3, 2p23.3) and galanin (GAL, 11q13.3); published functional evidence relates both of these to MDD and serotonergic signaling; (b) support for the bipolar disorder risk variant SNP rs1006737 in CACNA1C (P=0.020, odds ratio=1.10); and (c) lack of support for rs2251219, a SNP identified in a meta-analysis of affective disorder studies (P=0.51). We estimate that sample sizes 1.8- to 2.4-fold greater are needed for association studies of MDD compared with those for schizophrenia to detect variants that explain the same proportion of total variance in liability. Larger study cohorts characterized for genetic and environmental risk factors accumulated prospectively are likely to be needed to dissect more fully the etiology of MDD.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Quantile–quantile plots for the association analyses of (i) all cases and controls and (ii) recurrent early onset (iii) meta-analysis.

Similar articles

Cited by

References

    1. Australian Bureau of Statistics 4326.0—National Survey of Mental Health and Wellbeing: Summary of Results, 2007 http://wwwabsgovau/AUSSTATS/abs@nsf/mf/43260 .
    1. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602. - PubMed
    1. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU. Sex-differences in rates of depression—cross-national perspectives. J Affect Disord. 1993;29:77–84. - PubMed
    1. Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord. 2003;75:155–162. - PubMed
    1. Craddock N, Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet. 2006;14:660–668. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources